Medtronic plc. Ordinary Shares (MDT): Price and Financial Metrics
Medtronic plc. Ordinary Shares (MDT)
Today's Latest Price: $112.14 USD
Updated Dec 1 7:00pm
Add MDT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
MDT Stock Summary
- With a market capitalization of $152,837,275,176, Medtronic plc has a greater market value than 98.81% of US stocks.
- MDT's went public 34.94 years ago, making it older than 92.92% of listed US stocks we're tracking.
- The volatility of Medtronic plc's share price is greater than that of only 7.22% US stocks with at least 200 days of trading history.
- If you're looking for stocks that are quantitatively similar to Medtronic plc, a group of peers worth examining would be DHR, NVO, SAP, TMUS, and HON.
- Visit MDT's SEC page to see the company's official filings. To visit the company's web site, go to www.medtronic.com.
MDT Stock Price Chart Interactive Chart >
MDT Price/Volume Stats
| Current price | $112.14 | 52-week high | $122.15 |
| Prev. close | $113.70 | 52-week low | $72.13 |
| Day low | $111.92 | Volume | 5,035,459 |
| Day high | $115.13 | Avg. volume | 5,689,401 |
| 50-day MA | $107.43 | Dividend yield | 2.04% |
| 200-day MA | $99.70 | Market Cap | 150.74B |
Medtronic plc. Ordinary Shares (MDT) Company Bio
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The company was founded in 1949 and is based in Dublin, Ireland.
MDT Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $112.14 | $35.76 | -69% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Medtronic plc. To summarize, we found that Medtronic plc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. In terms of the factors that were most noteworthy in this DCF analysis for MDT, they are:
- Medtronic plc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 24.33% of tickers in our DCF set.
- MDT's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than only 24.33% of tickers in our DCF set.
- As a business, Medtronic plc experienced a tax rate of about 0% over the past twelve months; relative to its sector (Healthcare), this tax rate is higher than merely 0% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -69% |
| 1% | -69% |
| 2% | -69% |
| 3% | -68% |
| 4% | -68% |
| 5% | -68% |
Want more companies with a valuation profile/forecast similar to that of Medtronic plc? See ABT, SKVI, CPIX, DHR, and EHC.
Loading social stream, please wait...